The possible significance of Clostridium spp. in blood cultures

被引:26
作者
Benjamin, B.
Kan, M.
Schwartz, D.
Siegman-Igra, Y.
机构
[1] Tel Aviv Univ, Infect Dis Unit, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Microbiol Lab, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
bacteraemia; blood cultures; Clostridium spp; contamination; pseudobacteraemia; significance;
D O I
10.1111/j.1469-0691.2006.01464.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The significance of Clostridium spp. in blood cultures was evaluated by two methods. In the first part of the study, a group of 80 patients with Clostridium spp. bacteraemia was compared with a group of 100 patients with Bacillus spp. in blood cultures, making the assumption that Bacillus almost invariably represents contamination (pseudobacteraemia). Significant differences were found between the two groups, suggesting that growth of Clostridium did not represent pseudobacteraemia. Patients with Clostridium bacteraemia were older, had a higher frequency of gastrointestinal disease (especially colorectal tumours), were associated more frequently with polymicrobial bacteraemia, and had a higher mortality rate. In the second part of the study, each of the 80 cases of Clostridium bacteraemia was evaluated individually for clinical relevance by an infectious diseases expert. In two-thirds of the cases, isolates of Clostridium from blood were considered to be of clinical relevance, whereas in one-third of cases, the clinical significance of this finding was doubtful. It was concluded that growth of Clostridium spp. in blood cultures, even in the absence of one of the histotoxic syndromes, is often of clinical significance, and that such findings should be properly evaluated and not ignored.
引用
收藏
页码:1006 / 1012
页数:7
相关论文
共 22 条
  • [1] CLOSTRIDIUM SEPTICUM - INFECTIONS AND MALIGNANCY
    ALPERN, RJ
    DOWELL, VR
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 209 (03): : 385 - &
  • [2] ALPERN RJ, 1971, AM J CLIN PATHOL, V55, P717
  • [3] BODEY GP, 1991, CANCER, V67, P1928, DOI 10.1002/1097-0142(19910401)67:7<1928::AID-CNCR2820670718>3.0.CO
  • [4] 2-9
  • [5] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [6] Chen Yao-Ming, 2001, Journal of Microbiology Immunology and Infection, V34, P113
  • [7] FRY DE, 1981, SURG GYNECOL OBSTET, V153, P28
  • [8] GORBACH SL, 1975, J INFECT DIS S, V131, P81
  • [9] NON-SPORE-FORMING CLOSTRIDIAL BACTEREMIA
    GRASBERGER, RC
    PIETRAFITTA, JJ
    DECKERS, PJ
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1984, 25 (03) : 188 - 191
  • [10] Haddy RI, 2000, SCAND J INFECT DIS, V32, P27, DOI 10.1080/00365540050164173